AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34546172 — intervention group
Group type: EXPERIMENTAL
Intervention: In-depth interviews with participants who have moved within 6 months and follow-up interviews 12 months later.
Number of subjects: 2800
Study 34547326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic Acid (TUDCA)
Number of subjects: 0
Study 34547521 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab (12 months)
Number of subjects: 0
Study 34547521 — intervention group
Group type: COMPARATOR
Intervention: Placebo (12 months)
Number of subjects: 0
Study 34547521 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab (12 months) followed by alendronate (24 months)
Number of subjects: 0
Study 34547521 — intervention group
Group type: COMPARATOR
Intervention: Alendronate only (24 months)
Number of subjects: 0
Study 34547927 — intervention group
Group type: EXPERIMENTAL
Intervention: Penumbra System
Number of subjects: 650
Study 34548038 — intervention group
Group type: EXPERIMENTAL
Intervention: Mighty Mums intervention (motivational talks, physical and nutritional activities)
Number of subjects: 1301
Study 34548042 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine use
Number of subjects: 44
Study 34548042 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 44
Study 34548042 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysubstance use (heroin, methamphetamine, alcohol)
Number of subjects: 44
Study 34548050 — intervention group
Group type: EXPERIMENTAL
Intervention: Wasting (weight-for-length Z-score < -2)
Number of subjects: 6567
Study 34548050 — intervention group
Group type: EXPERIMENTAL
Intervention: Stunting (length-for-age Z-score < -2)
Number of subjects: 6567
Study 34548050 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent wasting-stunting
Number of subjects: 6567
Study 34548050 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for wasting and stunting
Number of subjects: 6567
Study 34548050 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior episodes of wasting and stunting
Number of subjects: 6567
Study 34548050 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior episodes of stunting
Number of subjects: 6567
Study 34548198 — intervention group
Group type: COMPARATOR
Intervention: NR-Minor
Number of subjects: 645
Study 34548198 — intervention group
Group type: COMPARATOR
Intervention: NR-Normal
Number of subjects: 645
Study 34548198 — intervention group
Group type: COMPARATOR
Intervention: Possible ABMR
Number of subjects: 645
Study 34548198 — intervention group
Group type: COMPARATOR
Intervention: ABMR
Number of subjects: 645
Study 34548198 — intervention group
Group type: EXPERIMENTAL
Intervention: TCMR and Early-injury
Number of subjects: 645
Study 34548198 — intervention group
Group type: EXPERIMENTAL
Intervention: NR-Minor and ABMR scores
Number of subjects: 645
Study 34548198 — intervention group
Group type: EXPERIMENTAL
Intervention: MMDx ABMR
Number of subjects: 645
Study 34548240 — intervention group
Group type: EXPERIMENTAL
Intervention: Current Hormone Replacement Therapy (HRT)
Number of subjects: 689
Study 34548240 — intervention group
Group type: COMPARATOR
Intervention: Never HRT
Number of subjects: 689
Study 34548321 — intervention group
Group type: EXPERIMENTAL
Intervention: LY3200882 monotherapy
Number of subjects: 139
Study 34548321 — intervention group
Group type: EXPERIMENTAL
Intervention: LY3200882 in combination therapy
Number of subjects: 139
Study 34548321 — intervention group
Group type: COMPARATOR
Intervention: LY3200882
Number of subjects: 139
Study 34548324 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition administered in the first 7 days of postnatal life
Number of subjects: 16292
Study 34548324 — intervention group
Group type: COMPARATOR
Intervention: No parenteral nutrition
Number of subjects: 16292
Study 34548350 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual physical activity measured by accelerometry
Number of subjects: 0
Study 34548350 — intervention group
Group type: EXPERIMENTAL
Intervention: Registry data on physical function (Danish Cerebral Palsy Follow-Up Programme)
Number of subjects: 0
Study 34548350 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated proxy-reported questionnaires on quality of life (Paediatric Quality of Life Inventory)
Number of subjects: 0
Study 34548350 — intervention group
Group type: EXPERIMENTAL
Intervention: Paediatric Outcomes Data Collection Instrument
Number of subjects: 0
Study 34548350 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary questions regarding sleep, screen time, and socioeconomic status
Number of subjects: 0
Study 34548371 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health assessment through self-report instruments and diagnostic interviews
Number of subjects: 1200
Study 34548371 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (QoL) assessment
Number of subjects: 1200
Study 34548371 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploration of mechanisms linking personality and perception of pandemic consequences
Number of subjects: 1200
Study 34548595 — intervention group
Group type: EXPERIMENTAL
Intervention: Poseltinib
Number of subjects: 0
Study 34549372 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral treatment (FBT)
Number of subjects: 241
Study 34549906 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy followed by autologous stem cell transplantation (ASCT)
Number of subjects: 0
Study 34549906 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment combinations
Number of subjects: 0
Study 34549906 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontline ASCT
Number of subjects: 0
Study 34550079 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity tracker-guided exercise program (arm B and C)
Number of subjects: 201
Study 34550079 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized weekly targets for physical activity (arm C)
Number of subjects: 201
Study 34550079 — intervention group
Group type: COMPARATOR
Intervention: Standard care (arm A)
Number of subjects: 201
Study 34550085 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial Ecosystem Therapeutic (MET)-2, daily orally administered capsule containing 40 bacterial strains for 6 weeks
Number of subjects: 60
Study 34550085 — intervention group
Group type: COMPARATOR
Intervention: Placebo, matching placebo for 6 weeks
Number of subjects: 60
Study 34550085 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial Ecosystem Therapeutic (MET)-2
Number of subjects: 60
Study 34550088 — intervention group
Group type: EXPERIMENTAL
Intervention: Joy Luck Academy (culturally sensitive social support intervention)
Number of subjects: 168
Study 34550088 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational information)
Number of subjects: 168
Study 34550442 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TME)
Number of subjects: 689
Study 34550527 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural barriers to physical activity
Number of subjects: 1299
Study 34550527 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age, higher BMI, lower educational level, no current work activity, co-morbidities, lacking physicians' exercise counseling
Number of subjects: 1299
Study 34550633 — intervention group
Group type: EXPERIMENTAL
Intervention: TOP2 poison chemotherapy
Number of subjects: 12
Study 34550754 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34550757 — intervention group
Group type: EXPERIMENTAL
Intervention: Poziotinib treatment
Number of subjects: 30
Study 34551181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) treatment
Number of subjects: 225
Study 34551181 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF-free regimen
Number of subjects: 225
Study 34551181 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher trough MMF concentrations
Number of subjects: 225
Study 34551181 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-KTRs)
Number of subjects: 225
Study 34551219 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 0
Study 34551219 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34551220 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 0
Study 34551220 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34551342 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation program
Number of subjects: 60
Study 34551507 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib
Number of subjects: 189
Study 34551507 — intervention group
Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 189
Study 34551725 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterans Administration Video Connect (VVC)
Number of subjects: 45
Study 34551738 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model for detecting shallow ACD
Number of subjects: 3753
Study 34551738 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model
Number of subjects: 3753
Study 34551765 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised participant information sheets developed through user testing
Number of subjects: 27805
Study 34551765 — intervention group
Group type: COMPARATOR
Intervention: Routine information sheets generated by research teams
Number of subjects: 27805
Study 34551886 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax (400 mg daily for days 1 to 28), Pomalidomide (daily for days 1 to 21), Dexamethasone (weekly for each 28-day cycle)
Number of subjects: 8
Study 34551886 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax (400 mg daily for days 1 to 28)
Number of subjects: 8
Study 34551940 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin B exposure (exact dosage and duration not specified)
Number of subjects: 0
Study 34551940 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain MRI (structural T1, resting-state functional connectivity, diffusion tensor imaging)
Number of subjects: 0
Study 34552007 — intervention group
Group type: EXPERIMENTAL
Intervention: Epigenetic inhibitors, specific agents not mentioned, duration not specified.
Number of subjects: 0
Study 34552007 — intervention group
Group type: COMPARATOR
Intervention: Immune checkpoint inhibitors, specific agents not mentioned, duration not specified.
Number of subjects: 0
Study 34552462 — intervention group
Group type: EXPERIMENTAL
Intervention: VN-NDT
Number of subjects: 30
Study 34552538 — intervention group
Group type: EXPERIMENTAL
Intervention: ARTISAN intervention (5-week, 15-hour participatory art and group-based intervention)
Number of subjects: 0
Study 34552538 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 34552548 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Wrist Traction
Number of subjects: 0
Study 34552548 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34552549 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility Rehab System for Mobility Training
Number of subjects: 0
Study 34552549 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34552864 — intervention group
Group type: EXPERIMENTAL
Intervention: ACY-241 (citarinostat) at 180 mg
Number of subjects: 17
Study 34552864 — intervention group
Group type: EXPERIMENTAL
Intervention: ACY-241 (citarinostat) at 360 mg
Number of subjects: 17
Study 34552864 — intervention group
Group type: EXPERIMENTAL
Intervention: ACY-241 (citarinostat) at 480 mg
Number of subjects: 17
Study 34552864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab at 240 mg
Number of subjects: 17
Study 34552864 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 17
Study 34552864 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-emergent adverse events
Number of subjects: 17
Study 34552937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic Nutritional Therapy
Number of subjects: 0
Study 34552937 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nutritional Therapy including Low-FODMAP Diet
Number of subjects: 0
Study 34552943 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34553156 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg administered in early follicular phase
Number of subjects: 12
Study 34553156 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg administered in midluteal phase
Number of subjects: 12
Study 34553156 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg administered in late follicular phase
Number of subjects: 12
Study 34553156 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 34553161 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 300 mg twice daily with estradiol 1 mg/norethindrone acetate 0.5 mg once daily
Number of subjects: 786
Study 34553161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 786
Study 34553294 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34553506 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH referral rule
Number of subjects: 250
Study 34553506 — intervention group
Group type: EXPERIMENTAL
Intervention: CARE referral rule
Number of subjects: 250
Study 34553506 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite referral rule for IRD
Number of subjects: 250
Study 34553956 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural responsivity to thin models and high-calorie foods
Number of subjects: 88
Study 34553956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie food-specific go/no-go paradigm
Number of subjects: 88
Study 34553956 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood induction
Number of subjects: 88
Study 34554139 — intervention group
Group type: EXPERIMENTAL
Intervention: High-priority research questions
Number of subjects: 597
Study 34554139 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-priority research questions
Number of subjects: 597
Study 34554139 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-priority research questions
Number of subjects: 597
Study 34554139 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus on research questions
Number of subjects: 597
Study 34554139 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding functional outcomes after injury
Number of subjects: 597
Study 34554228 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex polymerase chain reaction plus phenotypic detection algorithm
Number of subjects: 0
Study 34554228 — intervention group
Group type: COMPARATOR
Intervention: Routine cultures
Number of subjects: 0
Study 34554440 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 146
Study 34554440 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 146
Study 34554440 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in appetite
Number of subjects: 146
Study 34554440 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in taste
Number of subjects: 146
Study 34554440 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased sensation for sweet taste
Number of subjects: 146
Study 34554440 — intervention group
Group type: COMPARATOR
Intervention: Changes in taste and smell perceptions
Number of subjects: 146
Study 34554571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulthiame (STM)
Number of subjects: 355
Study 34554584 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib
Number of subjects: 26
Study 34554686 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone
Number of subjects: 1345
Study 34554686 — intervention group
Group type: COMPARATOR
Intervention: Intravenous dexamethasone
Number of subjects: 1345
Study 34554689 — intervention group
Group type: EXPERIMENTAL
Intervention: Viable Disc Tissue Allograft Supplementation
Number of subjects: 0
Study 34554689 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34554698 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Sensitivity Questionnaire (PSQ)
Number of subjects: 85
Study 34554698 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite pain score (calculated from PSQ, light unpleasantness threshold, and interaction between gender and eye color)
Number of subjects: 85
Study 34554698 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity to unpleasantness of sound
Number of subjects: 85
Study 34554698 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity to unpleasantness of light
Number of subjects: 85
Study 34554698 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 85
Study 34554698 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age and dark eyes
Number of subjects: 85
Study 34555181 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based physical activity interventions
Number of subjects: 66752
Study 34555420 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally and misoprostol 800 mcg buccally dispensed by mail-order pharmacy after in-person clinical assessment
Number of subjects: 240
Study 34555420 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally and misoprostol 800 mcg buccally dispensed by mail-order pharmacy
Number of subjects: 240
Study 34555554 — intervention group
Group type: EXPERIMENTAL
Intervention: Racing thoughts at bedtime in insomnia disorder
Number of subjects: 72
Study 34555554 — intervention group
Group type: EXPERIMENTAL
Intervention: Racing thoughts at bedtime
Number of subjects: 72
Study 34555554 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination and worry
Number of subjects: 72
Study 34555876 — intervention group
Group type: EXPERIMENTAL
Intervention: 4K vision system
Number of subjects: 29
Study 34555876 — intervention group
Group type: COMPARATOR
Intervention: 3D vision system
Number of subjects: 29
Study 34556062 — intervention group
Group type: EXPERIMENTAL
Intervention: Outer diameter (OD) of 3.5mm endotracheal tubes (ETTs) from different manufacturers
Number of subjects: 99
Study 34556062 — intervention group
Group type: EXPERIMENTAL
Intervention: Outer diameter (OD) of 3.0mm endotracheal tubes (ETTs)
Number of subjects: 99
Study 34556061 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid group
Number of subjects: 100
Study 34556061 — intervention group
Group type: COMPARATOR
Intervention: Routine care group
Number of subjects: 100
Study 34556061 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 34556099 — intervention group
Group type: EXPERIMENTAL
Intervention: Stakeholder engagement meetings with community representatives and adolescents
Number of subjects: 125
Study 34556099 — intervention group
Group type: EXPERIMENTAL
Intervention: Community perspectives on ethical considerations for involving adolescents in HIV research
Number of subjects: 125
Study 34556099 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed solutions for ethical involvement of adolescents in HIV research
Number of subjects: 125
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 103.1 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 116.4 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 129.6 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 142.9 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 100.3 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 111.5 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 116.0 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 128.6 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 100 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 110 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence of 120 steps/min
Number of subjects: 98
Study 34556146 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity of ≥6 METs
Number of subjects: 98
Study 34556171 — intervention group
Group type: EXPERIMENTAL
Intervention: First COVID-19 surge treatment
Number of subjects: 2625
Study 34556171 — intervention group
Group type: COMPARATOR
Intervention: Second COVID-19 surge treatment
Number of subjects: 2625
Study 34556176 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfers delivered through an mHealth system using fingerprint identification and mobile payments.
Number of subjects: 346
Study 34556176 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth system for cash transfers.
Number of subjects: 346
Study 34556176 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the mHealth system from the perspectives of PLHIV and clinicians.
Number of subjects: 346
Study 34556176 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured clinic observations of the mHealth system.
Number of subjects: 346
Study 34556182 — intervention group
Group type: EXPERIMENTAL
Intervention: Key opinion leader condition
Number of subjects: 180
Study 34556182 — intervention group
Group type: COMPARATOR
Intervention: Researcher-only condition
Number of subjects: 180
Study 34556189 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary HPV testing
Number of subjects: 23
Study 34556189 — intervention group
Group type: COMPARATOR
Intervention: Previous strategies of Pap testing or co-testing
Number of subjects: 23
Study 34556275 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve surgery after TEER
Number of subjects: 332
Study 34556281 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34556282 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral Transcatheter Aortic Valve Replacement with the JenaValve Trilogy System
Number of subjects: 0
Study 34556408 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic Peripheral Neuropathy (DPN)
Number of subjects: 5047
Study 34556408 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular Autonomic Neuropathy (CAN)
Number of subjects: 5047